Rare hypoparathyroidism

Rare hypoparathyroidism is a group of uncommon conditions characterized by deficient production or secretion of parathyroid hormone (PTH) by the parathyroid glands, or by impaired PTH action on target tissues. PTH is essential for maintaining calcium and phosphorus balance in the body. When PTH levels are insufficient, blood calcium levels fall (hypocalcemia) and phosphorus levels rise (hyperphosphatemia), leading to a range of clinical manifestations. This Orphanet grouping (ORPHA:181405) encompasses various rare etiologies of hypoparathyroidism, including genetic forms, autoimmune-mediated destruction of the parathyroid glands, and other rare causes distinct from the more common post-surgical hypoparathyroidism. The condition primarily affects the musculoskeletal, neurological, and renal systems. Key symptoms result from hypocalcemia and include muscle cramps, tingling and numbness in the fingers, toes, and around the mouth (perioral paresthesias), muscle spasms (tetany), seizures, and cardiac arrhythmias. Chronic hypocalcemia can lead to basal ganglia calcifications, cataracts, dental abnormalities, dry skin, brittle nails, and neuropsychiatric symptoms such as anxiety, depression, and cognitive impairment. Renal complications include nephrocalcinosis and nephrolithiasis due to impaired calcium handling by the kidneys. Treatment of rare hypoparathyroidism traditionally involves oral calcium supplementation and active vitamin D analogs (such as calcitriol or alfacalcidol) to maintain serum calcium levels within an acceptable range and alleviate symptoms. Recombinant human parathyroid hormone (rhPTH(1-84)) has been approved as an adjunctive therapy for patients whose hypocalcemia is inadequately controlled with conventional treatment. Regular monitoring of serum calcium, phosphorus, renal function, and urinary calcium excretion is essential to prevent complications such as kidney damage. Genetic counseling may be appropriate for hereditary forms of the condition.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Rare hypoparathyroidism